Efficacy of Ibutilide for Terminating Recent Onset Atrial Fibrillation- A Single Centre Study

Ibutilide is a class 3 antiarrythmic agent that is usedinfrequently. There are few studies on its usage, especiallyamong Indians.Materials & Methods: A retrospective study was conductedon patients in a tertiary care unit who had recently developedatrial fibrillation and were given the normal dose of ibutilide.During the study period, data was gathered from medicalrecords.Results: During the study period, ibutilide was given to a totalof 40 patients who met the inclusion criteria. The majority ofthe participants were under 60 years old and had only been inatrial fibrillation for less than 24 hours. In 70% of cases, atrialfibrillation could be successfully terminated with only a smallrisk of adverse events.Conclusion: Ibutilide is a safe and effective treatment forpeople who have recent onset atrial fibrillation.